Bioengineered Models to Study Microenvironmental Regulation of Glioblastoma Metabolism.

Bioengineered platforms Biomimetics Cancer metabolism Glioblastoma Mathematical modeling Microphysiological platforms Tumor microenvironment

Journal

Journal of neuropathology and experimental neurology
ISSN: 1554-6578
Titre abrégé: J Neuropathol Exp Neurol
Pays: England
ID NLM: 2985192R

Informations de publication

Date de publication:
19 11 2021
Historique:
entrez: 15 9 2021
pubmed: 16 9 2021
medline: 26 2 2022
Statut: ppublish

Résumé

Despite extensive research and aggressive therapies, glioblastoma (GBM) remains a central nervous system malignancy with poor prognosis. The varied histopathology of GBM suggests a landscape of differing microenvironments and clonal expansions, which may influence metabolism, driving tumor progression. Indeed, GBM metabolic plasticity in response to differing nutrient supply within these microenvironments has emerged as a key driver of aggressiveness. Additionally, emergent biophysical and biochemical interactions in the tumor microenvironment (TME) are offering new perspectives on GBM metabolism. Perivascular and hypoxic niches exert crucial roles in tumor maintenance and progression, facilitating metabolic relationships between stromal and tumor cells. Alterations in extracellular matrix and its biophysical characteristics, such as rigidity and topography, regulate GBM metabolism through mechanotransductive mechanisms. This review highlights insights gained from deployment of bioengineering models, including engineered cell culture and mathematical models, to study the microenvironmental regulation of GBM metabolism. Bioengineered approaches building upon histopathology measurements may uncover potential therapeutic strategies that target both TME-dependent mechanotransductive and biomolecular drivers of metabolism to tackle this challenging disease. Longer term, a concerted effort integrating in vitro and in silico models predictive of patient therapy response may offer a powerful advance toward tailoring of treatment to patient-specific GBM characteristics.

Identifiants

pubmed: 34524448
pii: 6370675
doi: 10.1093/jnen/nlab092
pmc: PMC9432143
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1012–1023

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS062184
Pays : United States

Informations de copyright

© 2021 American Association of Neuropathologists, Inc. All rights reserved.

Références

Front Oncol. 2021 Feb 22;11:582694
pubmed: 33692947
Biomaterials. 2019 Apr;198:63-77
pubmed: 30098794
Cells. 2017 Nov 22;6(4):
pubmed: 29165393
Brain. 2007 Oct;130(Pt 10):2596-606
pubmed: 17785346
Nat Neurosci. 2015 Apr;18(4):501-10
pubmed: 25730670
Metabolites. 2014 Aug 27;4(3):740-50
pubmed: 25167383
Cell. 2015 Sep 10;162(6):1229-41
pubmed: 26321679
Am J Pathol. 2012 May;180(5):2108-19
pubmed: 22440258
Am J Pathol. 2013 Oct;183(4):1293-1305
pubmed: 23928381
Annu Rev Pathol. 2014;9:1-25
pubmed: 23937436
Front Oncol. 2020 May 15;10:553
pubmed: 32500020
Front Oncol. 2017 Mar 01;7:20
pubmed: 28299282
Cancer Res. 2016 Apr 15;76(8):2465-77
pubmed: 26896279
Am J Pathol. 2018 Jan;188(1):29-38
pubmed: 29024634
PLoS One. 2017 Jun 5;12(6):e0177561
pubmed: 28582392
Cancer Rep. 2019 Dec;2(6):
pubmed: 32095788
Cancers (Basel). 2020 Jan 15;12(1):
pubmed: 31952173
Anal Cell Pathol (Amst). 2018 Jun 26;2018:5917470
pubmed: 30046513
Acta Neuropathol Commun. 2021 May 31;9(1):101
pubmed: 34059134
Cancer Cell. 2010 Jan 19;17(1):98-110
pubmed: 20129251
Brain. 2019 Apr 1;142(4):847-866
pubmed: 30946477
Biomaterials. 2011 Nov;32(31):7913-23
pubmed: 21820737
Sci Rep. 2016 Aug 23;6:31589
pubmed: 27549930
J Biomed Opt. 2015 Sep;20(9):098002
pubmed: 26405823
Cell Metab. 2019 Jan 8;29(1):124-140.e10
pubmed: 30293773
Lab Chip. 2019 Oct 9;19(20):3461-3471
pubmed: 31506657
Colloids Surf B Biointerfaces. 2018 Dec 1;172:665-673
pubmed: 30243220
Cancer Res. 2004 Jun 1;64(11):3892-9
pubmed: 15172999
Cell Metab. 2019 Jul 2;30(1):201-211.e6
pubmed: 31056286
Cancers (Basel). 2019 Aug 23;11(9):
pubmed: 31450721
Anal Methods. 2017 Apr 21;9(15):2275-2283
pubmed: 28674558
EMBO J. 2018 Dec 3;37(23):
pubmed: 30322894
Trends Cancer. 2015 Dec;1(4):252-265
pubmed: 27088132
Biochem J. 2016 Oct 1;473(19):3013-30
pubmed: 27458252
IEEE Trans Biomed Eng. 2017 Mar;64(3):519-527
pubmed: 27959794
Cancer Res. 2009 May 15;69(10):4167-74
pubmed: 19435897
Sci Rep. 2016 Feb 09;6:21557
pubmed: 26857460
EBioMedicine. 2019 Apr;42:252-269
pubmed: 30952620
Trends Endocrinol Metab. 2017 Jun;28(6):428-436
pubmed: 28318896
Sci Rep. 2017 Nov 10;7(1):15285
pubmed: 29127321
Cell. 2020 Jan 9;180(1):188-204.e22
pubmed: 31883794
Tissue Eng Part B Rev. 2014 Aug;20(4):314-27
pubmed: 24044776
Cancer Cell. 2007 Jan;11(1):69-82
pubmed: 17222791
Nat Commun. 2019 Oct 4;10(1):4529
pubmed: 31586101
Mol Cancer Res. 2014 Oct;12(10):1416-29
pubmed: 24962319
Ther Adv Med Oncol. 2019 Jun 21;11:1758835919853958
pubmed: 31258628
Cell. 2018 Sep 20;175(1):117-132.e21
pubmed: 30197082
Int J Mol Sci. 2018 Aug 31;19(9):
pubmed: 30200299
Oncotarget. 2016 Nov 29;7(48):78787-78803
pubmed: 27791206
Br J Cancer. 2017 Jun 27;117(1):102-112
pubmed: 28571041
Cancer Cell. 2017 Mar 13;31(3):326-341
pubmed: 28292436
N Engl J Med. 2013 Oct 17;369(16):1561-3
pubmed: 24131182
Am J Pathol. 2015 Jul;185(7):1820-33
pubmed: 25976245
NMR Biomed. 2012 Nov;25(11):1234-44
pubmed: 22419606
Cell Signal. 2011 Nov;23(11):1869-75
pubmed: 21756999
Cancer Res. 2009 May 15;69(10):4493-501
pubmed: 19366801
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
J Clin Invest. 2008 Dec;118(12):3930-42
pubmed: 19033663
Front Oncol. 2019 Mar 06;9:118
pubmed: 30895167
Nature. 2010 Dec 9;468(7325):824-8
pubmed: 21102434
Neuron. 2018 Nov 21;100(4):799-815.e7
pubmed: 30344046
In Vivo. 2020 Jan-Feb;34(1):199-211
pubmed: 31882480
Cancer Res. 2019 Oct 15;79(20):5218-5232
pubmed: 31488423
Acta Biochim Biophys Sin (Shanghai). 2013 Jan;45(1):18-26
pubmed: 23257292
Mol Carcinog. 2017 Nov;56(11):2355-2371
pubmed: 28618012
Neurosurgery. 2015 Oct;77(4):N16
pubmed: 26379178
JAMA. 2013 Nov 6;310(17):1842-50
pubmed: 24193082
Cancer Res. 2017 Aug 1;77(15):4171-4184
pubmed: 28536277
Macromol Biosci. 2017 Aug;17(8):
pubmed: 28379642
Oncotarget. 2018 Feb 28;9(21):15705-15720
pubmed: 29644003
Nature. 2019 Mar;567(7748):341-346
pubmed: 30842654
Cell. 2014 Dec 18;159(7):1603-14
pubmed: 25525878
Anal Chem. 2014 May 6;86(9):4145-50
pubmed: 24678888
Cell. 2013 Mar 28;153(1):139-52
pubmed: 23540695
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5618-27
pubmed: 27608497
Nat Cell Biol. 2016 Dec;18(12):1336-1345
pubmed: 27820599
Free Radic Biol Med. 2013 Sep;64:20-30
pubmed: 23712003
Oncotarget. 2017 Jul 25;8(30):49178-49190
pubmed: 28380457
J Transl Med. 2013 Apr 10;11:94
pubmed: 23574623
Curr Neuropharmacol. 2016;14(6):567-83
pubmed: 26791479
Cell Rep. 2017 Jan 10;18(2):468-481
pubmed: 28076790
Nature. 2008 Oct 23;455(7216):1061-8
pubmed: 18772890
Front Mater. 2018 Jun;5:
pubmed: 30581816
Curr Opin Biomed Eng. 2017 Mar;1:87-95
pubmed: 29082354
Nat Neurosci. 2019 May;22(5):729-740
pubmed: 30962630
Science. 1956 Aug 10;124(3215):269-70
pubmed: 13351639
J Pathol. 2014 May;233(1):74-88
pubmed: 24481573
Oncotarget. 2017 Jan 3;8(1):1438-1448
pubmed: 27903965
Matrix Biol. 2020 Jan;85-86:112-127
pubmed: 31189077
Cold Spring Harb Symp Quant Biol. 2011;76:313-24
pubmed: 22105806
Nat Med. 2018 Jul;24(7):1036-1046
pubmed: 29892070
Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19611-6
pubmed: 22106302
Metab Eng. 2017 Sep;43(Pt B):156-172
pubmed: 28087332
Front Cell Dev Biol. 2017 Apr 26;5:43
pubmed: 28491867
Am J Pathol. 2012 May;180(5):1768-71
pubmed: 22449951
Am J Pathol. 2017 May;187(5):940-953
pubmed: 28284719
Oncotarget. 2017 May 23;8(39):64932-64953
pubmed: 29029402
Cell Mol Life Sci. 2021 Jan;78(1):195-206
pubmed: 32088728
Stem Cell Res Ther. 2015 Aug 28;6:157
pubmed: 26316122
Neuro Oncol. 2017 Jan;19(1):43-54
pubmed: 27365097
Am J Pathol. 2016 Jul;186(7):1724-35
pubmed: 27338107
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Oncotarget. 2017 Jul 4;8(27):44015-44031
pubmed: 28467795
Bull Math Biol. 2015 May;77(5):846-56
pubmed: 25795318
Nat Rev Immunol. 2012 Mar 22;12(4):253-68
pubmed: 22437938

Auteurs

Joseph Chen (J)

From the Department of Bioengineering, University of Louisville, Louisville, Kentucky, USA (JC, CJC, HBF); Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, USA (JC, DMM, HBF); Department of Neurological Surgery, University of Louisville, Louisville, Kentucky, USA (HL, BJW); Department of Medicine, University of Louisville, Louisville, Kentucky, USA (PS, DMM); Department of Radiation Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA (DMM, BJW, HBF); Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA (HBF); Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA (ELB).

Hyunchul Lee (H)

From the Department of Bioengineering, University of Louisville, Louisville, Kentucky, USA (JC, CJC, HBF); Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, USA (JC, DMM, HBF); Department of Neurological Surgery, University of Louisville, Louisville, Kentucky, USA (HL, BJW); Department of Medicine, University of Louisville, Louisville, Kentucky, USA (PS, DMM); Department of Radiation Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA (DMM, BJW, HBF); Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA (HBF); Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA (ELB).

Philipp Schmitt (P)

From the Department of Bioengineering, University of Louisville, Louisville, Kentucky, USA (JC, CJC, HBF); Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, USA (JC, DMM, HBF); Department of Neurological Surgery, University of Louisville, Louisville, Kentucky, USA (HL, BJW); Department of Medicine, University of Louisville, Louisville, Kentucky, USA (PS, DMM); Department of Radiation Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA (DMM, BJW, HBF); Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA (HBF); Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA (ELB).

Caleb J Choy (CJ)

From the Department of Bioengineering, University of Louisville, Louisville, Kentucky, USA (JC, CJC, HBF); Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, USA (JC, DMM, HBF); Department of Neurological Surgery, University of Louisville, Louisville, Kentucky, USA (HL, BJW); Department of Medicine, University of Louisville, Louisville, Kentucky, USA (PS, DMM); Department of Radiation Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA (DMM, BJW, HBF); Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA (HBF); Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA (ELB).

Donald M Miller (DM)

From the Department of Bioengineering, University of Louisville, Louisville, Kentucky, USA (JC, CJC, HBF); Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, USA (JC, DMM, HBF); Department of Neurological Surgery, University of Louisville, Louisville, Kentucky, USA (HL, BJW); Department of Medicine, University of Louisville, Louisville, Kentucky, USA (PS, DMM); Department of Radiation Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA (DMM, BJW, HBF); Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA (HBF); Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA (ELB).

Brian J Williams (BJ)

From the Department of Bioengineering, University of Louisville, Louisville, Kentucky, USA (JC, CJC, HBF); Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, USA (JC, DMM, HBF); Department of Neurological Surgery, University of Louisville, Louisville, Kentucky, USA (HL, BJW); Department of Medicine, University of Louisville, Louisville, Kentucky, USA (PS, DMM); Department of Radiation Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA (DMM, BJW, HBF); Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA (HBF); Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA (ELB).

Elaine L Bearer (EL)

From the Department of Bioengineering, University of Louisville, Louisville, Kentucky, USA (JC, CJC, HBF); Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, USA (JC, DMM, HBF); Department of Neurological Surgery, University of Louisville, Louisville, Kentucky, USA (HL, BJW); Department of Medicine, University of Louisville, Louisville, Kentucky, USA (PS, DMM); Department of Radiation Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA (DMM, BJW, HBF); Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA (HBF); Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA (ELB).

Hermann B Frieboes (HB)

From the Department of Bioengineering, University of Louisville, Louisville, Kentucky, USA (JC, CJC, HBF); Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, USA (JC, DMM, HBF); Department of Neurological Surgery, University of Louisville, Louisville, Kentucky, USA (HL, BJW); Department of Medicine, University of Louisville, Louisville, Kentucky, USA (PS, DMM); Department of Radiation Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA (DMM, BJW, HBF); Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA (HBF); Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA (ELB).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH